RPG Investment Advisory LLC boosted its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 101.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 265,554 shares of the industrial products company's stock after purchasing an additional 133,411 shares during the period. Xylem comprises approximately 2.3% of RPG Investment Advisory LLC's holdings, making the stock its 14th largest holding. RPG Investment Advisory LLC owned about 0.11% of Xylem worth $31,723,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. grew its holdings in shares of Xylem by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company's stock worth $3,465,122,000 after acquiring an additional 362,127 shares during the period. Royal Bank of Canada grew its holdings in shares of Xylem by 7.9% during the 4th quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company's stock worth $506,985,000 after acquiring an additional 320,500 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Xylem by 8.7% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,750,377 shares of the industrial products company's stock worth $435,119,000 after acquiring an additional 301,070 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in shares of Xylem by 689.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company's stock worth $443,074,000 after acquiring an additional 3,239,203 shares during the period. Finally, Northern Trust Corp grew its holdings in shares of Xylem by 2.9% during the 1st quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company's stock worth $401,743,000 after acquiring an additional 94,560 shares during the period. Hedge funds and other institutional investors own 87.96% of the company's stock.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on the company. Royal Bank Of Canada upped their price target on Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 30th. Raymond James Financial raised Xylem to a "hold" rating in a report on Thursday, May 15th. Stifel Nicolaus raised their target price on Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Robert W. Baird decreased their target price on Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a report on Wednesday, April 30th. Finally, Citigroup reaffirmed a "buy" rating and issued a $152.00 target price (up from $137.00) on shares of Xylem in a report on Monday, July 14th. Six analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Xylem has a consensus rating of "Moderate Buy" and a consensus price target of $151.57.
Get Our Latest Stock Report on XYL
Xylem Price Performance
Shares of Xylem stock traded down $0.9850 during trading on Monday, reaching $142.7550. 897,193 shares of the stock traded hands, compared to its average volume of 1,463,510. The company has a market capitalization of $34.75 billion, a price-to-earnings ratio of 37.08, a P/E/G ratio of 2.49 and a beta of 1.11. The business has a fifty day simple moving average of $134.27 and a two-hundred day simple moving average of $126.39. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $145.33.
Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. The firm had revenue of $2.30 billion during the quarter, compared to analyst estimates of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The business's quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.09 earnings per share. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Sell-side analysts expect that Xylem Inc. will post 4.65 EPS for the current year.
Xylem Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be given a dividend of $0.40 per share. The ex-dividend date is Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem's dividend payout ratio (DPR) is presently 41.56%.
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.